Stay updated with breaking news from Lawrencea Kenyon. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Algernon Pharmaceuticals Inc said that it had included nicotinate and pamoate as novel salt forms of DMT as part of its intellectual property patent...
Algernon Pharmaceuticals Inc said that it had included nicotinate and pamoate as novel salt forms of DMT as part of its intellectual property patent...
Algernon Pharmaceuticals Inc said that it had included nicotinate and pamoate as novel salt forms of DMT as part of its intellectual property patent...
.jpg)
NA Proactive news snapshot: BioHarvest Sciences, Marble Financial, ElectraMeccanica Vehicles, Ion Energy UPDATE … A glance at some of the day's highlights from the Proactive Investors US and Canada newswires Your daily round-up from the world of Proactive BioHarvest Sciences Inc. (CSE:BHSC) (FRA:8MV) has announced the launch of direct-to-consumer sales of its flagship product VINIA in the United States, via its vinia.com website. After years of developing its BioFarming technology, the company said it is proud to bring the first product based on this technology to the US market...
Share: ISELIN, N.J., May 12, 2021 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (NASDAQ:OTLK), a late clinical-stage biopharmaceutical company working to develop the first FDA-approved ophthalmic formulation of bevacizumab for use in retinal indications, today announced it will host a Virtual Clinical Day for analysts and accredited institutional investors with live video webcast (details below) on Thursday, May 20, 2021 from 11:00 AM – 1:00 PM ET. During the Virtual Clinical Day, Outlook Therapeutics will provide an overview of its lead program, ONS-5010 / LYTENAVA™ (bevaciz...